Search

everythinglearnresearchcommunity

for

Search:↓

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Temporal triangular alopecia may be linked to sebaceous nevus and shows a new pinkish background feature.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Surgeons suggested a standard system for hair transplant methods to improve communication and results.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

An automated method accurately assesses melanoma risk using 3D body images to analyze skin traits.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Fluorescent tattoos are a good way to mark the scalp for hair treatments because they're accurate, invisible in normal light, and have low risk.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Dermoscopy improves diagnosis and treatment planning for trichostasis spinulosa.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Triamcinolone regrows hair better but relapses more than anthralin.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

KID syndrome should be reclassified as an ectodermal dysplasia.

The meeting highlighted the complexity and variability of skin conditions and differing opinions on their diagnoses and treatments.